National Oesophago-Gastric Cancer Audit, 2014

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. Accessing the data The data are being made available on the data.gov website. Each year files of data from the National Oesophago-Gastric Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and organisation code. What does the data cover? The data measures levels of completeness for data submitted to the National Oesophago-Gastric Cancer Audit and measures of performance and participation in the audit at trust level for key performance measures. Further details of these can be found in the annexes of the National Oesophago-Gastric Cancer Audit Report 2014. - Audit participation by NHS Trust and data completeness for the key fields. - Measures about the process of care given to patients. - Information about care outcomes and treatment. These data do not list individual patient information, nor do they contain any patient identifiable data. Are all Trusts included? All Trusts in England and Wales that manage patients diagnosed with oesophago-gastric cancer are included. What period does the data cover? The National Oesophago-gastric Cancer Audit 2014 covers the time period from 1st April 2011 to 31st March 2013 and includes hospital sites within England and Wales.推动临床审计数据透明化。 2011年7月7日，首相在致内阁大臣的透明度与开放数据信函中作出承诺，将公开国家临床审计与患者结局项目（National Clinical Audit and Patient Outcomes Programme）下属国家审计项目产生的临床审计数据。 国家食管胃结合部癌审计（National Oesophago-Gastric Cancer Audit）聚焦食管胃结合部（Oesophago-Gastric, OG）癌症患者的照护质量。该审计对所有食管胃结合部癌患者（包括接受根治性治疗与姑息治疗的患者）的诊疗流程与治疗结局进行评估。自2012年4月起，审计范围扩展至食管高级别上皮内瘤变（Oesophageal High-Grade Dysplasia, HGD）患者。 国家食管胃结合部癌审计是一项高影响力的全国性合作临床审计项目，由英国卫生与社会护理信息中心、大不列颠及爱尔兰上消化道外科医师协会（Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland, AUGIS）、英国胃肠病学会（British Society of Gastroenterologists, BSG）以及英格兰皇家外科医学院临床效能单元联合运营。 本审计旨在提升食管胃结合部癌患者的照护质量与生存率，符合《英国国民保健制度癌症规划》（NHS Cancer Plan）与英国国家卫生与临床优化研究所（NICE）指南的相关要求。 数据获取方式 相关数据将在data.gov网站发布。国家食管胃结合部癌审计的年度数据将以逗号分隔值（CSV）格式公开。国民保健信托机构与医疗网络将通过名称及机构代码进行标识。 数据覆盖范围 本数据用于评估提交至国家食管胃结合部癌审计的各项数据的完整率，同时针对核心绩效指标，统计各医疗信托机构的审计参与度与绩效表现。相关指标的详细说明可参阅《2014年国家食管胃结合部癌审计报告》的附件内容。 - 国民保健信托机构的审计参与情况，以及核心字段的数据完整率 - 患者诊疗流程相关指标 - 患者照护结局与治疗相关信息 本数据集不包含任何个体患者信息，也未收录任何可识别患者身份的数据。 是否覆盖所有医疗信托机构？ 所有在英格兰与威尔士境内收治食管胃结合部癌患者的国民保健信托机构均已纳入本数据集。 数据覆盖的时间范围 《2014年国家食管胃结合部癌审计》覆盖的时间范围为2011年4月1日至2013年3月31日，涵盖英格兰与威尔士境内的所有医疗机构院区。